A new wave of sensors, responding to the challenge of global healthcare transformation, opens new business opportunities for mobile healthcare and emerging non-invasive devices
- Focus on mobile healthcare (mHealth) and sensor requirements
- Sensor technology trends for mHealth and the Internet of Medical Things (IoMT)
- Specific section on non-invasive sensors
- Introduction of new sensor technologies: printed electronics
- Changes in business models, and value chain impact
- Integration of optical MEMS sensors
- Description of emerging MEMS: ultrasonic sensors (CMUT & PMUT), neural implants, and more
KEY FEATURES OF THE REPORT
- How healthcare is transforming,and the impact on MEMS/BioMEMS sensors
- Key drivers for BioMEMS device usage
- BioMEMS sensors used: key application per device type (pressure sensors, accelerometers, microphones, microfluidics, ultrasonic sensors, etc..)
- Global bioMEMS market: key metrics, in volume and value for the period 2017 – 2023, market dynamics (CAGR2017-2023)
- Focus on components: market forecast, major players, market share, supply chain
- Technology trends contributing to new healthcare applications
- How are emerging non-invasive sensors responding to healthcare’s new challenges?
OBJECTIVES OF THE REPORT
This report’s objectives are to:
- Explain which MEMS are used in which healthcare applications, and why
- Provide an overview of the main players at every level of the supply chain, including market share
- Identify the threats and opportunities related to bioMEMS, along with market and technology trends
- Highlight promising technologies and booming applications
- Compare the bioMEMS market to the global MEMS market and explain the similarities/differences
- Discuss where and how bioMEMS will be used in the future
Table of Contents
Executive Summary 12
- Definition and segmentation
- Global Healthcare Transformation
Global Healthcare Trends 55
- Drivers and Challenges
- A shift from hospital to homecare – Towards a patient-centric approach
Mobile Healthcare (mHealth) 68
- Introduction to mHealth
- mHealth infrastructure
- mHealth sensor requirements
- Market forecast on wearable devices
- mHealth supply chain
Emerging Non-Invasive Sensors 88
- Definition and scope
- Drivers & challenges for adoption
- From implantable to non-invasive devices
- Technology trends & roadmap
- Non-invasive ecosystem and supply chain
Consumer Healthcare 146
- The healthcare industry’s new grail?
- Challenges in consumer healthcare
- Players for consumer healthcare – Involvement of MEMS players
2016 – 2023 BioMEMS Market Data & Forecasts 155
- 2016 – 2018 M&A Activity
- BioMEMS Market Forecast 2016 – 2023 in volume and value
- Global ASP evolution
- BioMEMS market dynamism: CAGR2018 – 2023
Technology Trends 170
- Technology challenges at the sensor level
- Biocompatibility and materials
Changes in Business Models 181
- From sensors to integrated solutions
- The fight to acquire value
Description of MEMS Components and Applications 187
- Pressure sensors, Microphones, Accelerometers, Gyroscopes, Temperature sensors, Optical MEMS, Microfluidic chips/microdispensers, Flow sensors, Gas sensors, Emerging MEMS (Neural implants, Ultrasound sensors, …)
MEMS TECHNOLOGY IS CONSOLIDATING ITS HEALTHCARE MARKET PENETRATION, AND FOR THE NEXT FIVE YEARS WILL CONTINUE ITS HUGE 14.8% GROWTH
More than ever, companies are showing a growinginterest in the healthcare domain. In the last 2 -3 years, major players like Google, Apple, and Amazon have highlighted challenging projects, i.e. measuring blood glucose via smartwatches orsmart lenses. Also, sensor makers are developingnew technologies and platforms to answer thespecific requirements of medical grade products.
Demand for MEMS devices is increasing exponentiallythanks to a democratization of medical devices that’sbringing them closer to consumers and creating ahigh demand for portable and wearable devicesenabling patient monitoring at the point of need. Inorder to satisfy demand, almost all MEMS foundriesare proposing manufacturing services dedicated tohealthcare applications.
With the addition of microfluidic chips (Si-based, polymer-based, glass-based) the BioMEMS market, represented by silicon MEMS devices used for lifesciences and healthcare applications, is expectedto more than double – from $3B in 2017 to $6.9Bin 2023, with a CAGR of 14.9% from 2017 – 2023. This makes bioMEMS a must-have for today’s globalsensor makers.
Microfluidics demand still drives the BioMEMS market thanks to point of care applications and anincreasing demand for next generation sequencing.Also, the “acquisitions race” by large diagnosticscompanies is still ongoing. Pressure sensors are moremature sensor devices used in respiratory and bloodmonitoring, still reaching volumes of several hundredmillion units per year. Nevertheless, these maturedevices are expected to enjoy a new wave of interestthanks to fresh demand for smart connected objectslike inhalers and sleep apnea monitoring systems.
It is also worth noting that the transformationof global healthcare is spurring strong effortsto acquire new functionalities and access tonew diagnostic capabilities with micromachinedultrasound transducers (CMUT and PMUT) andgas sensors. Moreover, MEMS sensor innovationhas triggered developments in neurotechnologies,with neural implants for therapeutic applications(still at research level today) paving the wayfor better quality-of-life for patients with neurodegenerative diseases.
This report describes in detail the different sensortypes, markets, and trends, as well as a global overviewof the dynamic BioMEMS market, from 2017 – 2023.
HEALTHCARE TRANSFORMATION: AN OPPORTUNITY FOR BIOMEMS DEVICES
Healthcare is rapidly changing thanks to a convergence of factors: economical, societal, and technological. First, cost of care has risen to an incredible level for health organizations and governments. Budgets have reached a critical threshold while demography is exploding and chronic diseases are the scourge of industrialized countries. According to the World Health Organization (WHO), 422M people have diabetes, and 1.5B are at risk for cardiovascular events. The $2T yearly cost of chronic diseases supported by society is now unsustainable.
Second, people have easier access to information through apps and the web via smartphones and tablets. More than 2B smartphones are used worldwide, ready to connect with smartwatches or ear pods measuring heartbeat and analysing gestures.
Third, MEMS technology is now mature enough to offer medical-grade measurement with miniaturized and low power-consumption sensors, at a lower price than conventional technologies.
BioMEMS devices are key solutions for a high level of electronic integration, contributing to development of a new generation of easy-to-use medical devices for consumer and patients, with a lower rate of hospitalization and the ability to help avoid unnecessary visits. For example, asthma detection devices integrating MEMS microphones and accelerometers can prevent an asthma attack by alerting the patient through his smartphone at exactly the right moment, prompting him to take his medicine and thus avoid a medical emergency.
Trends for consumer healthcare and mHealth, as well as major trends for BioMEMS adoption, are explained in Yole Développement’s (Yole) report.
WHAT DOES THE FUTURE LOOKS LIKE: THE NEXT GENERATION OF SENSORS AND EMERGING MEMS
Along with sensor miniaturization and replacing electret microphones for hearing aids with MEMS microphones, new MEMS devices are creating opportunities for next-generation medical devices. After years of development, ultrasound transducers based on capacitive detection (CMUT) or piezoelectric detection (PMUT) are finally emerging, with the first handheld imaging diagnostic systems announced by Butterfly Network. Microneedles are also attracting great interest as a minimally invasive device able to capture or dispense fluids in the skin’s interstitial layers. This report describes the status of minimally invasive and non-invasive sensors, and provides a roadmap by application which highlights the requirements and challenges for non-invasive medical devices. Much effort is being invested in non-invasive devices for better patient comfort, and painless leroutines so that patients stick with treatment. For instance, Apple has invested lots of money and manpower to develop an optical non-invasive sensor in its smartwatch, which constantly checks the wearer’s blood glucose level.
Exceeding “wearable”, the next generation of sensorintegrating medical devices should be “forgettable”: that is, sensors must adapt to all wearables, textiles, and other accessories. Flexibility and stretchability are pending parameters for the next sensor generation, likely in the form of body “stickers” that detect the presence of certain molecules in sweat. Meanwhile, electrochemical sensors are leveraging printed electronics development and new biocompatible substrate research, and should offer supplementary.
AAC Technologies, Abaxis, Aceinna, AGC, Agilent Technologies, Alere, Alps, Amazon Web Services, Amphenol, ams, Analog Devices, AND, ASE Group, Ava, Avita, Axxin, Becton Dickinson, BerkeleyUniversity, Biolinq, Biomerieux, Biorad, Biotricity, Boehringer Ingelheim, Bosch, Boston Scientific, Bruker, Butterfly Networks, Cambridge Cconsultants, CEA LETI, Cepheid, Continental, Corning, Daktari,Danaher, Debiotech, Denso, Dreem, EMPA, Empatica, EPFL, Epigem, Excelitas Technologies, eXo Imaging,Facebook, Food & Drug Aadministration (FDA), Feeltronix, Figaro, First Ssensor, Fitbit, Fluidigm, Fraunhofer FEP, Fujifilm Dimatix, GenePOC, Global Foundries, Goertek, Google, Great Basin, Hamamatsu, Heimann Ssensor, Hitachi, Honeywell, Horiba, Hosiden, Huawei, IDEX, IFTEST, iHealth, Illumina, IMT, Infineon, Infra, Invetech, Jawbone, Johnson & Johnson, JRC, Kenzen, Kionix, Knowles, Kolo Medical, Kulite, KWJ,Maradin, Maxim Integrated, MC10, Medtronic, Meggitt Ssensing, Melexis, MEMSCAP, MEMSIC, MeritSensor, Metemis, Micralyne, Microfluidic Chipshop, Micronics, Micronit, Microport, MiniFab, Mistic, MIT, Murata, Murata, Nanoflex, Neuronexus, Nissha, Nokia, Nokia, Novartis, Noviosense, NXP, OligoScan, Omron, Omron, Orange, Oticon, Owlstone Medical, Pacific Biosciences, Perkin Elmer, Philips, PK Vitality,Propeller Hhealth, Qualcomm Life, Radiant, Resound, Roche, Samsung, Sano, Schott, Schrader, Sensata, Sensimed, Sensirion, Siargo, Siemens, Silex Microsytems, Silterra, Sintef, Si-Ware, SMI, Sonion, Sonova, Sony DADC, Spex, Standford University, Starkey, STMicroelectronics, Stratec, TDK, TDK Tronics, TE,Teledyne Dalsa, Texas Instruments, Thermofisher Scientific, ThinXXS, Thync, Translume, TSMC, TTPGroup, Tufts, Valedo, Valencell, Valtronic, Verasonics, Verily, Vermon, Vesper, ViCardio, Vitalconnect, Widex, Withings, XFAB, Xsensio, Zoetis, and many others.
Related Reports & Monitors
Power GaN 2019: Epitaxy, Devices, Applications & Technology Trends
Market & Technology
Power GaN 2019 – Patent Landscape Analysis
Need to discuss?
We are open for discussionContact us